Telomir Pharmaceuticals (TELO) SEC Filings & 10K Form → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free TELO Stock Alerts $6.86 +0.07 (+1.03%) (As of 04/26/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media Recent Telomir Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView03/29/20244:28 PMTelomir Pharmaceuticals (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 02/08/202411:15 PMTelomir Pharmaceuticals (Filer)Form EFFECT02/08/20244:46 PMEAGLE CRAIG (Reporting)Telomir Pharmaceuticals (Issuer)Form 3Initial statement of beneficial ownership of securities 02/08/20244:48 PMMcColl Hugh III (Reporting)Telomir Pharmaceuticals (Issuer)Form 3Initial statement of beneficial ownership of securities 02/08/20244:52 PMJerman Michael Allen (Reporting)Telomir Pharmaceuticals (Issuer)Form 3Initial statement of beneficial ownership of securities 02/08/20244:55 PMFuentes Nathen (Reporting)Telomir Pharmaceuticals (Issuer)Form 3Initial statement of beneficial ownership of securities 02/08/20244:58 PMTelomir Pharmaceuticals (Issuer)Tuck Talhia (Reporting)Form 3Initial statement of beneficial ownership of securities 02/08/20245:01 PMBay Shore Trust (Reporting)McNulty Brian Patrick (Reporting)Telomir Pharmaceuticals (Issuer)Form 3Initial statement of beneficial ownership of securities 02/08/20244:34 PMKroenig Bradley (Reporting)Telomir Pharmaceuticals (Issuer)Form 3Initial statement of beneficial ownership of securities 02/08/20244:39 PMChapman Christopher C JR (Reporting)Telomir Pharmaceuticals (Issuer)Form 3Initial statement of beneficial ownership of securities 02/08/20244:40 PMNicholoudis Christos (Reporting)Telomir Pharmaceuticals (Issuer)Form 3Initial statement of beneficial ownership of securities 02/06/20244:26 PMTelomir Pharmaceuticals (Filer)Form 8-A12B01/03/20249:50 AMTelomir Pharmaceuticals (Filer)Form S-1/A12/19/20234:19 PMTelomir Pharmaceuticals (Filer)Form S-1/A12/14/20234:09 PMTelomir Pharmaceuticals (Filer)Form S-1/A11/13/20238:36 PMTelomir Pharmaceuticals (Filer)Form S-1Registration statement under Securities Act of 1933 (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: ACIU SEC Filings ALDX SEC Filings ACRV SEC Filings TSVT SEC Filings PBYI SEC Filings XBIT SEC Filings NKTR SEC Filings OVID SEC Filings QURE SEC Filings AEON SEC Filings SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:TELO) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingUrgent Nvidia WarningAltimetryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHis win rate puts Warren Buffett to shame… Investing DailyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
